articleThe LancetApr 1, 2005Closed access

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

MDMarc DecramerMRMaureen Rutten‐van MölkenPRPN Richard DekhuijzenTTThierry TroostersCVCees van Herwaarden

KU Leuven · Erasmus University Rotterdam · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

681
total citations
FWCI
41.16
Percentile
100%
References
44
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Medicine
  • Acetylcysteine
  • COPD
  • Placebo
  • Chronic bronchitis
  • Exacerbation
  • Internal medicine
  • Hazard ratio
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.